Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next?Unlock AI-picked Stocks

Zacks Investment Ideas feature highlights: Anthem, UnitedHealth Group and Molina Healthcare

Published 12/29/2021, 02:29 AM
Updated 07/09/2023, 06:31 AM

For Immediate Release

Chicago, IL – December 29, 2021 – Today, Zacks Investment Ideas features: Anthem, Inc. ANTM, UnitedHealth Group, Inc. UNH and Molina Healthcare (NYSE:MOH), Inc. MOH.

Neutralize Higher Health Insurance Premiums in 2022

It’s no secret – health insurance premiums have only gone one way over time. Over the last decade, family premiums for employer-sponsored coverage have jumped 47% according to the 2021 Kaiser Family Foundation Employer Health Benefits Survey. Roughly 155 million people in the U.S. rely on employer-sponsored coverage.

The rate of growth in premiums has outpaced both inflation (19%) as well as wages (31%) over the same time frame. Receiving family health insurance from work now costs employers and employees an average of $22,221 a year according to the Kaiser report. Workers contributed an average of about $6,000 this year with employers covering the rest.

The outlook becomes much worse when we factor in non-employer health insurance premiums. Since the Affordable Care Act (keyword “affordable”) was signed into law back in 2010, the average family health insurance premium in the U.S. has more than tripled. While most of the non-employer premiums are now subsidized by taxpayers, the rate of increase is quite alarming.

As an investor, sometimes it pays to think of yourself as a handyman or contractor. You have a set of tools to accomplish different jobs, and you must adapt to the needs of each specific project. In our current investing environment, health insurance premiums have skyrocketed – and we must decipher which tools to utilize to best counteract these higher costs.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The biggest beneficiaries of rising premiums have undoubtedly been health insurers. These insurers’ stocks are the tools we can use to accomplish our investing goal of neutralizing increasing healthcare costs.

The iShares U.S. Healthcare Providers ETF IHF seeks to track the investment results of an index composed of domestic equities in the healthcare providers sector. IHF has climbed nearly 25% this year and is currently hitting all-time highs. New highs are a sign of strength and investors would be wise to take note of three companies within this ETF that are also making new highs. These firms are three of the top ten holdings within IHF and account for roughly 35% of the total IHF holdings.

The iShares U.S. Healthcare Providers ETF offers investors exposure to companies that provide health insurance, diagnostics, and specialized treatment. Below we will delve into three top health insurers that are outperforming the market.

Anthem

Anthem operates as a domestic health benefits company, offering an array of network-based managed care benefit plans to large and small groups, individuals, as well as Medicaid and Medicare markets. ANTM also offers pharmacy, dental, vision, life and disability insurance benefits. Founded in 1944 and headquartered in Indianapolis, IN, Anthem serves over 44 million medical members through its affiliated health plans.

Anthem has substantially improved its top-line in recent years, witnessing a CAGR of 9% from 2015-2020 on the heels of higher membership numbers and premium rate increases. The company has boosted revenues 15% year-over-year through the first nine months of 2021 to $35.8 billion. Given ANTM’s strong Medicaid and Medicare businesses, we expect the revenue growth trend to continue into 2022.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Anthem’s strong cash position has driven consistent dividend payouts and stock repurchases. In Q3 of this year, ANTM repurchased shares worth $480 million. In total, the company expects to repurchase shares worth $1.6 billion in 2021, which should further support its stock price.

ANTM accounts for over 9% of the total IHF ETF holdings mentioned earlier. The company has delivered an average earnings surprise of +4.71% over the previous four quarters. ANTM most recently reported EPS in October of $6.79, a 6.93% positive surprise over consensus. The firms’ shares have outperformed the market this year with a 46% return.

The Zacks Consensus Estimate for 2021 EPS stands at $25.96, which represents a 15.48% increase relative to 2020. ANTM is scheduled to report earnings on January 26th.

UnitedHealth Group

UnitedHealth Group operates as a diversified healthcare company in the United States. The company provides a wide range of healthcare products and services including health maintenance organizations (HMOs), preferred provider organizations (PPOs), as well as managed fee-for-service programs. Founded in 1977 and headquartered in Minnetonka, MN, UNH offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees, as well as Medicare and Medicaid beneficiaries.

UNH boasts the largest and most diverse membership base within the managed-care market which gives the company a significant competitive advantage. The company has acquired a number of competing healthcare providers over the years and also built its prescription drug business through OptumRx via the acquisition of Catamaran in 2015.

UNH revenues have grown consistently as the firm has witnessed a CAGR of 5.1% in the five-year period ending in 2020. Through the first nine months of 2021, the company’s strong market position helped to increase revenues by 11.6%. We expect this trend to continue in the years ahead.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

UNH accounts for nearly 23% of the aforementioned IHF ETF holdings and has delivered an earnings beat in each quarter for the past eight years running. The company has posted a trailing four-quarter average surprise of +8.66%, supporting the stock’s 45.1% ascent this year.

What the Zacks Model Unveils

The Zacks Earnings ESP (Expected Surprise Prediction) seeks to identify companies that have recently seen positive earnings estimate revision activity. This proprietary model has proven to be very useful for locating positive earnings surprises in advance. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time according to our 10-year backtest.

UnitedHealth Group is a Zacks #3 (Hold) stock and has an Earnings ESP of +0.33%. The positive earnings surprise trend is set to continue. The Zacks Consensus Estimate for 2021 EPS is currently $18.85, translating to growth of 11.67% compared to last year. UNH is slated to report on January 19th.

Molina Healthcare

Molina Healthcare provides managed healthcare services to low-income families and individuals through the Medicare and Medicaid programs and via state insurance marketplaces. Founded in 1980 and headquartered in Long Beach, CA, MOH is a multi-state health care organization with approximately 4 million members.

Through the first nine months of 2021, Molina Healthcare has managed to increase revenues by 43.5% relative to last year. Total 2021 revenues are expected to be $27.5 billion on the heels of increased membership and higher premiums.

MOH has averaged a 4% positive earnings surprise over the past four quarters. The company most recently reported EPS in October of $2.83, a 2.54% surprise over estimates. MOH stock has followed suit, climbing 51.28% on the year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The current Zacks Consensus Estimate for 2021 earnings sits at $13.37, a 25.3% increase relative to 2020. Looking out at next year, analysts are anticipating healthy EPS growth of 27.28% to $17.02. MOH is expected to report earnings on February 9th, 2022.

As health insurance premiums continue to rise, these three health insurers are poised to continue their outperformance.

Follow us on Twitter (NYSE:TWTR): https://twitter.com/ZacksResearch

Join us on Facebook (NASDAQ:FB): https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.

Click here for the 4 trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (NYSE:UNH): Free Stock Analysis Report

Molina Healthcare, Inc (MOH): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

iShares U.S. Healthcare Providers ETF (IHF): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.